Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking

Barbara Valastro, PhD

Senior Director Patient Insights and Solutions, Portfolio Transformation and Insights, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Articles by Barbara Valastro, PhD

Improving Diversity in Clinical Trial Volunteer Participation by Addressing Racial and Ethnic Representation Among the Clinical Research Workforce

ByMaria I. Florez,Emily Botto,Zoma Foster, PhD,Earl Seltzer,Barbara Valastro, PhD,Linda Ashmore,Kenneth Getz, MBA

June 13th 2022

2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.

Latest Updated Articles

Trending on Applied Clinical Trials Online

The Design Flaws Trial Simulations Surface That Traditional Planning Misses

ACT Brief: AI Expands Endpoint Options, CRO Oversight Documentation, and Kidney Cancer Approval

Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It

Quantifying the Financial Value of RBQM: Q&A with Sylviane de Viron, CluePoints, and Abigail Dirks, Tufts CSDD

How AI Is Changing Endpoint Selection Before a Trial Even Starts